<info type="GeneOrGeneProduct">Protein-Trap Insertional Mutagenesis</info> Uncovers New <info type="GeneOrGeneProduct">Genes</info> Involved in <info type="OrganismTaxon">Zebrafish</info> <info type="DiseaseOrPhenotypicFeature">Skin Development</info>, Including a <info type="GeneOrGeneProduct">Neuregulin 2a</info>-Based <info type="GeneOrGeneProduct">ErbB</info> Signaling Pathway Required during <info type="DiseaseOrPhenotypicFeature">Median Fin Fold Morphogenesis</info>.

<info type="DiseaseOrPhenotypicFeature">Skin disorders</info> are widespread, but available treatments are limited. A more comprehensive understanding of <info type="DiseaseOrPhenotypicFeature">skin development mechanisms</info> will drive identification of new treatment targets and modalities. Here we report the <info type="GeneOrGeneProduct">Zebrafish Integument Project</info> (ZIP), an expression-driven platform for identifying new <info type="GeneOrGeneProduct">skin genes</info> and <info type="DiseaseOrPhenotypicFeature">phenotypes</info> in the vertebrate model <info type="OrganismTaxon">Danio rerio</info> (<info type="OrganismTaxon">zebrafish</info>). In vivo selection for <info type="DiseaseOrPhenotypicFeature">skin-specific expression</info> of <info type="GeneOrGeneProduct">gene-break transposon</info> (GBT) mutant lines identified eleven new, revertible <info type="SequenceVariant">GBT alleles</info> of <info type="GeneOrGeneProduct">genes</info> involved in <info type="DiseaseOrPhenotypicFeature">skin development</info>. Eight <info type="GeneOrGeneProduct">genes</info>--<info type="GeneOrGeneProduct">fras1</info>, <info type="GeneOrGeneProduct">grip1</info>, <info type="GeneOrGeneProduct">hmcn1</info>, <info type="GeneOrGeneProduct">msxc</info>, <info type="GeneOrGeneProduct">col4a4</info>, <info type="GeneOrGeneProduct">ahnak</info>, <info type="GeneOrGeneProduct">capn12</info>, and <info type="GeneOrGeneProduct">nrg2a</info>--had been described in an integumentary context to varying degrees, while <info type="GeneOrGeneProduct">arhgef25b</info>, <info type="GeneOrGeneProduct">fkbp10b</info>, and <info type="GeneOrGeneProduct">megf6a</info> emerged as novel <info type="GeneOrGeneProduct">skin genes</info>. Embryos homozygous for a <info type="SequenceVariant">GBT insertion</info> within <info type="GeneOrGeneProduct">neuregulin 2a</info> (<info type="GeneOrGeneProduct">nrg2a</info>) revealed a novel requirement for a <info type="GeneOrGeneProduct">Neuregulin 2a</info> (<info type="GeneOrGeneProduct">Nrg2a</info>)-<info type="GeneOrGeneProduct">ErbB2</info>/<info type="GeneOrGeneProduct">3-AKT</info> signaling pathway governing the <info type="DiseaseOrPhenotypicFeature">apicobasal organization</info> of a subset of <info type="DiseaseOrPhenotypicFeature">epidermal cells</info> during <info type="DiseaseOrPhenotypicFeature">median fin fold</info> (<info type="DiseaseOrPhenotypicFeature">MFF</info>) <info type="DiseaseOrPhenotypicFeature">morphogenesis</info>. In <info type="GeneOrGeneProduct">nrg2a</info> mutant larvae, the basal <info type="GeneOrGeneProduct">keratinocytes</info> within the apical <info type="GeneOrGeneProduct">MFF</info>, known as <info type="DiseaseOrPhenotypicFeature">ridge cells</info>, displayed reduced <info type="GeneOrGeneProduct">pAKT</info> levels as well as reduced apical domains and exaggerated basolateral domains. Those defects compromised proper <info type="DiseaseOrPhenotypicFeature">ridge cell elongation</info> into a flattened <info type="DiseaseOrPhenotypicFeature">epithelial morphology</info>, resulting in thickened <info type="DiseaseOrPhenotypicFeature">MFF edges</info>. Pharmacological inhibition verified that <info type="GeneOrGeneProduct">Nrg2a</info> signals through the <info type="GeneOrGeneProduct">ErbB receptor tyrosine kinase network</info>. Moreover, knockdown of the <info type="GeneOrGeneProduct">epithelial polarity regulator</info> and <info type="GeneOrGeneProduct">tumor suppressor</info> <info type="GeneOrGeneProduct">lgl2</info> ameliorated the <info type="GeneOrGeneProduct">nrg2a</info> mutant <info type="DiseaseOrPhenotypicFeature">phenotype</info>. Identifying <info type="GeneOrGeneProduct">Lgl2</info> as an antagonist of <info type="GeneOrGeneProduct">Nrg2a-ErbB signaling</info> revealed a significantly earlier role for <info type="GeneOrGeneProduct">Lgl2</info> during <info type="DiseaseOrPhenotypicFeature">epidermal morphogenesis</info> than has been described to date. Furthermore, our findings demonstrated that successive, coordinated <info type="DiseaseOrPhenotypicFeature">ridge cell shape changes</info> drive apical <info type="DiseaseOrPhenotypicFeature">MFF development</info>, making <info type="DiseaseOrPhenotypicFeature">MFF ridge cells</info> a valuable model for investigating how the coordinated regulation of <info type="DiseaseOrPhenotypicFeature">cell polarity</info> and <info type="DiseaseOrPhenotypicFeature">cell shape changes</info> serves as a crucial mechanism of <info type="DiseaseOrPhenotypicFeature">epithelial morphogenesis</info>.